DALLAS, April 29, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Cord Blood America Inc. (OTCBB:CBAI). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The full report is available at: www.microstockprofit.com/ads/CBAI
Cord Blood America Inc. (CBAI) is engaged in the business of collecting, testing, processing and preserving umbilical cord blood. The Company is primarily a holding company whose subsidiaries include Cord Partners Inc. (Cord), CorCell Co. Inc., CorCell Ltd., CBA Professional Services Inc. D/B/A BodyCells Inc. (BodyCells), CBA Properties Inc. (Properties), Career Channel Inc, D/B/A Rainmakers International (Rain) and Family Marketing Inc. (Family). In addition, the Company provides private cord blood stem cell preservation services to families in the United States. It also engages in collecting, processing, and preserving peripheral blood and adipose tissue stem cells, which allows individuals to privately preserve their stem cells for potential future use in stem cell therapy.
Message Board Search for CBAI: http://www.boardcentral.com/boards/CBAI
In the report, the analyst notes:
"Total liabilities decreased 62% to $5.2 million at the end of 2009 compared to $13.6 million at the conclusion of 2008. The decrease includes a reduction in promissory notes from $6.8 million at December 31, 2008, to $161,886 at December 31, 2009, and a $2.2 million decrease in accounts payable and accrued expenses.
"CBAI recently announced that it has signed a Letter of Intent to purchase controlling interest in BioCells Inc., headquartered in Argentina, with affiliates under development in Peru, Colombia, Bolivia, Panama and Puerto Rico. BioCells, the second largest stem cell storage company in Argentina, is profitable, with annual revenues in 2009 of $1.2 million (USD), and 12 locations throughout that country, plus recent expansion into Uruguay and Paraguay. On February 8, 2010, CBAI announced that BioCells finalized an agreement to process and store cord blood specimens with Cord Blood America in Las Vegas."
To read the entire report visit: www.microstockprofit.com/ads/CBAI
See what investors are saying about CBAI at penny stock forum
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on MicroStockProfit please visit: http://www.microstockprofit.com
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.